Search details
1.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36759721
2.
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Int J Cancer
; 151(10): 1760-1769, 2022 11 15.
Article
in English
| MEDLINE | ID: mdl-35678328
3.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34811502
4.
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Oncologist
; 27(1): e29-e36, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35305093
5.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Gastric Cancer
; 25(4): 783-793, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35352176
6.
Results of the observational prospective RealFLOT study.
BMC Cancer
; 21(1): 1086, 2021 Oct 08.
Article
in English
| MEDLINE | ID: mdl-34625033
7.
Personalized therapeutic strategies in HER2-driven gastric cancer.
Gastric Cancer
; 24(4): 897-912, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33755862
8.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33392769
9.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32369650
10.
Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials.
Oncologist
; 25(9): 780-786, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32272500
11.
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Gastric Cancer
; 23(6): 1064-1074, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32372141
12.
The Landscape of Actionable Gene Fusions in Colorectal Cancer.
Int J Mol Sci
; 20(21)2019 Oct 25.
Article
in English
| MEDLINE | ID: mdl-31731495
13.
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Br J Cancer
; 118(7): 955-965, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29531324
14.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Article
in English
| MEDLINE | ID: mdl-30130791
15.
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer.
Tumori
; : 3008916241253130, 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38726768
16.
Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges.
Cells
; 13(7)2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38607025
17.
Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study.
Clin Cancer Res
; 30(2): 436-443, 2024 01 17.
Article
in English
| MEDLINE | ID: mdl-37610454
18.
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials.
Eur J Cancer
; 203: 114043, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38598921
19.
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
Cell Oncol (Dordr)
; 46(3): 661-676, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36753044
20.
Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms.
J Exp Clin Cancer Res
; 42(1): 298, 2023 Nov 11.
Article
in English
| MEDLINE | ID: mdl-37951921